Dr. Rudnick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
127 S San Vicente Blvd
Ste A6600
Los Angeles, CA 90048Phone+1 310-423-8100Fax+1 310-967-8739
Summary
- Dr. Jeremy Rudnick is a neurologist in Los Angeles, CA and is affiliated with Cedars-Sinai Medical Center. He received his medical degree from State University of New York Downstate Medical Center College of Medicine and has been in practice 15 years. He specializes in neurooncology and is experienced in behavioral neurology / neuropsychiatry.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 2002 - 2005
State University of New York Downstate Medical Center College of MedicineClass of 2002
Certifications & Licensure
CA State Medical License 2004 - 2026
NY State Medical License 2006 - 2008- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma Start of enrollment: 2008 Feb 01
- The Addition of Temozolomide to Conditioning for Autologous Transplantation in Relapsed & Refractory CNS Lymphoma Start of enrollment: 2010 Oct 14
- A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma Start of enrollment: 2013 Dec 01
Publications & Presentations
PubMed
- 271 citationsPhase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastomaSurasak Phuphanich, Christopher J. Wheeler, Jeremy Rudnick, Mia Mazer, HongQian Wang
Cancer Immunology, Immunotherapy. 2013-01-01 - 166 citationsRegulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial.E. Antonio Chiocca, John S. Yu, Rimas V. Lukas, Isaac H. Solomon, Keith L. Ligon
Science Translational Medicine. 2019-08-14 - 38 citationsEGFR/ErbB2-Targeting Lapatinib Therapy for Aggressive Prolactinomas.Odelia Cooper, Vivien Bonert, Jeremy Rudnick, Barry D. Pressman, Janet Lo
The Journal of Clinical Endocrinology and Metabolism. 2021-01-23
Press Mentions
From Glioblastoma to Endurance Races: A Story of TenacityJanuary 12th, 2021
Maria’s Beauty Secrets, How to Worry Usefully + Brain Tumor Warning SignsJune 1st, 2018
How Valerie Harper Survived a Fatal Cancer Diagnosis: ‘It’s a Miracle She’s Still Here’November 20th, 2017- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
